Envestnet Asset Management Inc. Increases Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)
Envestnet Asset Management Inc. boosted its position in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 11.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 50,111 shares of the biopharmaceutical company’s stock after purchasing an additional 5,135 shares during the period. Envestnet Asset Management Inc.’s […]
